116 related articles for article (PubMed ID: 23739500)
1. [Asthenic disorders and cognitive dysfunction in patients with tension headache].
Chutko LS; Surushkina SIu; Rozhkova AV; Iakovenko EA; Bykova IuL; Nikishina IS
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):31-5. PubMed ID: 23739500
[TBL] [Abstract][Full Text] [Related]
2. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
[TBL] [Abstract][Full Text] [Related]
3. [The effect of cerebrolysin on moderate cognitive impairment in cerebral vascular insufficiency (a clinical and electrophysiological study)].
Damulin IV; Koberskaia NN; Mkhitarian EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(5):32-8. PubMed ID: 18379494
[TBL] [Abstract][Full Text] [Related]
4. [Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia].
Duma SN
Ter Arkh; 2013; 85(12):100-5. PubMed ID: 24640678
[TBL] [Abstract][Full Text] [Related]
5. [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin].
Vereshchagin NV; Suslina ZA; Timerbaeva SL; Kashina EM; Gnezditskiĭ VV; Maksimova MIu; Rebrova OIu; Smirnova IN
Ter Arkh; 2001; 73(4):22-7. PubMed ID: 11494441
[TBL] [Abstract][Full Text] [Related]
6. [Cerebrolysin in the treatment of brain injuries of moderate severity].
Talypov AE; Myachin MY; Kuksova NS; Kordonsky AY
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):98-106. PubMed ID: 25591645
[TBL] [Abstract][Full Text] [Related]
7. [Cognitive impairment in children with organic asthenic disorder].
Chutko LS; Surushkina SY; Yakovenko EA; Anisimova TI; Cherednichenko DV; Didur MD; Chekalova SA
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(9. Vyp. 2):92-99. PubMed ID: 37942979
[TBL] [Abstract][Full Text] [Related]
8. [Prognosis of cognitive deficit progression in aged patients with mild cognitive impairment under prolonged therapy (a three year observation)].
Gavrilova SI; Kolykhalov IV; Fedorova IaB; Kalyn IaB; Selezneva ND; Samorodov AV; Miasoedov SN; Boksha IS
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(3):45-53. PubMed ID: 23612410
[TBL] [Abstract][Full Text] [Related]
9. [Cerebrolysin treatment of mild cognitive impairment of vascular genesis].
Damulin IV; Mkhitarian EA; Koberskaia NN
Ter Arkh; 2007; 79(6):65-9. PubMed ID: 17684971
[TBL] [Abstract][Full Text] [Related]
10. [Mental processing in primary headache in children and adolescents].
Zgorzalewicz M
Przegl Lek; 2006; 63 Suppl 1():18-23. PubMed ID: 17471818
[TBL] [Abstract][Full Text] [Related]
11. [Results of multicenter study of efficacy and safety of divaza in the treatment of the asthenic and mild to moderate cognitive disorders in elderly and senile subjects].
Parfenov VА; Kamchatnov PR; Vorobyova ОV; Gustov АV; Glushkov КS; Doronina ОB
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):43-50. PubMed ID: 29053120
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of chosen cognitive functions in children and adolescents with primary headaches].
Zgorzalewicz M; Mojs E
Przegl Lek; 2006; 63 Suppl 1():24-8. PubMed ID: 17471819
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of asthenic disorders with tanakan].
Milopol'skaia IM
Ter Arkh; 2001; 73(10):45-7. PubMed ID: 11763515
[TBL] [Abstract][Full Text] [Related]
14. [Neuropsychological evaluation of long-term therapy of Alzheimer's disease using different cerebrolysin dosages].
Roshchina IF; Gavrilova SI; Zharikov GA; Kalyn IaB; Kolykhalov IV; Selezneva ND
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):52-5. PubMed ID: 15704485
[TBL] [Abstract][Full Text] [Related]
15. [Current conceptions of neurocytoprotective therapy].
Gomazkov OA; Afanas'ev VV; Rumiantseva SA; Stupin VA; Silina EV; Sokhova OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12 Pt 2):58-63. PubMed ID: 22792751
[TBL] [Abstract][Full Text] [Related]
16. [Neureprotective drugs efficiency in patients with chronic tension headaches].
Medvedeva LA; Gnezdilov OI; Syrovegin AV; Samoĭlova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(5):38-41. PubMed ID: 16768224
[TBL] [Abstract][Full Text] [Related]
17. [Influence of cytoflavin on symptoms of asthenia, emotional disorders and autonomic regulation in patients with organic asthenic disorder].
Polunina AG; Osinovskaia NA; Gudkova AN; Gekht AB
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(2):28-33. PubMed ID: 24662341
[TBL] [Abstract][Full Text] [Related]
18. Cognitive function in tension-type headache.
Waldie KE; Welch D
Curr Pain Headache Rep; 2007 Dec; 11(6):454-60. PubMed ID: 18173981
[TBL] [Abstract][Full Text] [Related]
19. A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration.
Muresanu DF; Alvarez XA; Moessler H; Buia M; Stan A; Pintea D; Moldovan F; Popescu BO
J Neurol Sci; 2008 Apr; 267(1-2):112-9. PubMed ID: 18048059
[TBL] [Abstract][Full Text] [Related]
20. [An effect of long-term cerebrolysin therapy in combination with neuroleptics on behavioral and cognitive disturbances in endogenous childhood autism].
Radzivil MG; Bashina VM
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):21-5. PubMed ID: 16548370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
